HIT Clinical Trials in Chapel Hill, North Carolina
3 recruitingChapel Hill, North Carolina
Showing 1–3 of 3 trials
Recruiting
Phase 4
Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
PouchitisPouches, IleoanalPouch, Ileal
University of North Carolina, Chapel Hill25 enrolled5 locationsNCT06864403
Recruiting
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
Brain MetastasesRadiation ExposureNeurocognitive Deficit+1 more
UNC Lineberger Comprehensive Cancer Center15 enrolled1 locationNCT04073966
Recruiting
Phase 4
Rifaximin for the Secondary Prevention of Recurrent Pouchitis
Pouchitis
University of North Carolina, Chapel Hill16 enrolled2 locationsNCT06312683